Aptose Biosciences Inc. cotiza a 1.69 USD y tiene una capitalización bursátil de $4M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed P…
| Periodo | 2025-05 | 2025-03 | 2024-08 | 2024-05 |
|---|---|---|---|---|
| Real | $-2.61 | $-34.90 | $-12.90 | $-21.90 |
| Estimado | $-2.67 | $-6.77 | $-17.40 | $-24.60 |
| Sorpresa | +2.2% | -415.5% | +25.9% | +11.0% |
| Métrica | APTOF | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -254.4% | -32.0% | -222.4% |
| Current Ratio | 0.69 | 2.84 | -2.15 |
| Debt / Equity | — | 0.28 | — |